Illumina Adds CDx Indication to European TruSight Oncology Test ...

Illumina Introduces New Pan-Cancer Companion Diagnostic to ...

(NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced the addition of a companion diagnostic (CDx) ...

The CDx pan-cancer indication will allow the identification of patients with NTRK gene fusions who may benefit from therapy with Bayer's ...

TruSight Oncology Comprehensive (EU) | CE-marked IVD CGP

TruSight Oncology Comprehensive (EU) is indicated as a companion diagnostic (CDx) test to identify cancer patients with solid tumors who are positive for NTRK1, ...

Illumina Adds CDx Indication to European TruSight Oncology Test ...

The CDx pan-cancer indication will allow the identification of patients with NTRK gene fusions who may benefit from therapy with Bayer's Vitrakvi ...

FDA approves Illumina cancer biomarker test with two companion ...

Illumina has a growing pipeline of CDx claims under development through partnerships with pharmaceutical companies, which will be added to TSO ...

Illumina adds new CDx indication to TruSight Oncology test

Illumina has introduced a new pan-cancer companion diagnostic, adding new indications to its TruSight Oncology (TSO) Comprehensive (EU) ...

New Pan-Cancer CDx Added to the TruSight Oncology Test

... indication has been added to the TruSight Oncology ... Illumina launched the TSO test for the evaluation of multiple tumor genes in Europe.

Illumina Unveils Groundbreaking Comprehensive Genomic Profiling ...

(NASDAQ:ILMN) today announced the launch of TruSight™ Oncology (TSO) Comprehensive (EU), a single test that assesses multiple tumor genes and ...

Illumina's TruSight Test in EU Gets Companion Dx Indication

Illumina has added a companion diagnostic (CDx) indication to its CE-marked in vitro diagnostic TruSight Oncology (TSO) test in the EU. This ...

Cancer Companion Diagnostic (CDx) Partnerships - Illumina

Distributable diagnostic solutions, including companion diagnostics (CDx) indications on TruSight Oncology Comprehensive (EU), will enable labs to perform ...

FDA approves Illumina cancer biomarker test with two companion ...

TruSight Oncology Comprehensive is the first US FDA-approved, distributable comprehensive genomic profiling IVD kit with pan-cancer companion ...

TruSight Oncology Comprehensive (EU) - Illumina

indicated as a CDx test to identify cancer patients with solid ... Current as of February 2023. Table 6: CDx indications. CDx indication.

Illumina Obtains CE-IVD Marking for European Version of TSO ...

NEW YORK – Illumina said on Tuesday that it has received CE-IVD marking for its TruSight Oncology Comprehensive (EU) assay this month.

TruSight Oncology Comprehensive (EU) FAQs - Illumina

Table 1: CDx indication. Tumor type. Biomarkers. Targeted therapy. Solid tumors. NTRK1, NTRK2, NTRK3 gene fusions. VITRAKVI® (larotrectinib). Read the TruSight ...

Illumina wins new indication for TruSight Oncology in Europe

Illumina has received a new pan-cancer companion diagnostic (CDx) indication to the CE Mark for its TruSight Oncology Comprehensive (EU) test kit, ...

Illumina Partners with Merck to Develop and Commercialize ...

Illumina will develop a new HRD CDx test for the EU and the UK to aid in the identification of ovarian cancer patients with positive HRD status ...

CDx development Diagnostics News - 360Dx

Qiagen CDx for GI Cancer Treatment Ayvakit Gets FDA Approval ... The test detects a mutation in a platelet-derived growth factor receptor gene that is associated ...

Press Release - Illumina

Based on the content of TSO 500, Illumina will be adding an in vitro diagnostic (IVD) test to the TruSight Oncology product family. This ...

Illumina receives FDA approval for TruSight Oncology ...

Analyst QuickTake: In May 2022 , Illumina added the CDx indication to its in vitro diagnostic TruSight Oncology tests. The test was already ...

Illumina Launches Research Test Codeveloped With Merck To ...

"We look forward to using this assay routinely in our lab for future projects. Combining HRD assessment with TruSight Oncology 500 in one ...